Skip to main content
Premium Trial:

Request an Annual Quote

Roche NimbleGen, Signature Genomic Laboratories

Premium
Roche NimbleGen last week launched its Gene Expression 12x135K Microarray format, a new multiplex gene expression array on its HD2 platform.
 
The 12-plex format enables users to analyze 12 independent samples simultaneously on a single slide, the company said. With 135,000 long oligonucleotide probes per array, complete transcriptome coverage can also be achieved.
 
NimbleGen is offering eight eukaryotic catalog designs in the new format – human, mouse, rat, A. thaliana, C. elegans, D. melanogaster, S. cerevisiae, and S. pombe. The company said it also offers custom-designed arrays in the new format.
 

 
Signature Genomic Laboratories last week announced that it has waived the 25 percent deposit previously required of patients for insurance billing.
 
Rather than pay a deposit prior to the initiation of testing, patients with private insurance can now request an insurance benefits investigation prior to or concurrent with sample processing through Signature's Patient Advocacy Program. Signature's patient advocacy team will communicate with the patient's insurance carrier on the patient's behalf to determine coverage.
 
Signature offers array-based cytogenetics testing for mental retardation and birth defects through its lab in Spokane, Wash.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.